Patents by Inventor Kevin Poupard

Kevin Poupard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Tools for Screening Agents Exhibiting an Activity on Receptors of the Tumor Necrosis Factor Receptor Superfamily
    Publication number: 20130079246
    Abstract: The present invention provides novel chimeric receptors and methods of screening using the chimeric receptors. The chimeric receptors comprise an extracellular domain of a tumor necrosis factor receptor superfamily (TNFRSF) receptor and an intracellular domain with kinase activity stemming from a receptor tyrosine kinase. According to an embodiment, the chimeric receptor comprises a full-length TNFRSF receptor. The present invention provides means for screening and testing of modulators of TNFRSF receptors.
    Type: Application
    Filed: May 5, 2011
    Publication date: March 28, 2013
    Applicant: ADDEX PHARMA SA
    Inventors: Thibaut De Smedt, Laurent Galibert, Anne-Renee Van Der Vuurst De Vries, Kevin Poupard
  • Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors
    Publication number: 20130052663
    Abstract: The present invention provides novel chimeric receptors and methods of screening using the chimeric receptors. The chimeric receptors comprise an extracellular domain of a type 1 single pass transmembrane receptor (T1SPTR) and an intracellular domain with kinase activity stemming from a receptor tyrosine kinase. According to an embodiment, the chimeric receptor comprises a full-length T1SPTR. According to another embodiment the chimeric receptor comprises a full-length or truncated tumor necrosis factor receptor (TNFR) or interleukin receptors, or cytokine receptors, or transforming growth factor receptors. The present invention provides means for screening of modulators of TNFRs or interleukin receptors, or cytokine receptors, or transforming growth factor receptors.
    Type: Application
    Filed: May 5, 2011
    Publication date: February 28, 2013
    Applicant: ADDEX PHARMA SA
    Inventors: Thibaut De Smedt, Laurent Galibert, Anne-Renee Van Der Vuurst De Vries, Kevin Poupard